Passiva PLT
Krystin Meidell is an accomplished regulatory affairs professional with extensive experience in the medical device and diagnostics sectors. Currently serving as Director of Global Regulatory Strategy at AbbVie since September 2021, Krystin's career includes pivotal roles at Biogen, Regulatory and Quality Solutions LLC, Myriad Genetics, and CR Bard, where responsibilities encompassed regulatory strategy development, lifecycle management, and compliance with international regulatory requirements. Krystin also has a solid academic background, holding a Master's degree in Engineering Management from Tufts University and a Bachelor's degree in Chemical Engineering from Carnegie Mellon University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Passiva PLT
Passiva PLT has developed a cross-sector platform technology that will democratize phototherapy, removing barriers such as high costs and inconvenience, and impacting the lives of millions of people.